Metabolomics analysis of the lactobacillus plantarum ATCC 14917 response to antibiotic stress

Background Lactobacillus plantarum has been found to play a significant role in maintaining the balance of intestinal flora in the human gut.

However, it is sensitive to commonly used antibiotics and is often incidentally killed during treatment.

We attempted to identify a means to protect L. plantarum ATCC14917 from the metabolic changes caused by two commonly used antibiotics, ampicillin, and doxycycline.

We examined the metabolic changes under ampicillin and doxycycline treatment and assessed the protective effects of adding key exogenous metabolites.

Results Using metabolomics, we found that under the stress of ampicillin or doxycycline, L. plantarum ATCC14917 exhibited reduced metabolic activity, with purine metabolism a key metabolic pathway involved in this change.

We then screened the key biomarkers in this metabolic pathway, guanine and adenosine diphosphate (ADP).

The exogenous addition of each of these two metabolites significantly reduced the lethality of ampicillin and doxycycline on L. plantarum ATCC14917.

Because purine metabolism is closely related to the production of reactive oxygen species (ROS), the results showed that the addition of guanine or ADP reduced intracellular ROS levels in L. plantarum ATCC14917.

Moreover, the killing effects of ampicillin and doxycycline on L. plantarum ATCC14917 were restored by the addition of a ROS accelerator in the presence of guanine or ADP.

Conclusions The metabolic changes of L. plantarum ATCC14917 under antibiotic treatments were determined.

Moreover, the metabolome information that was elucidated can be used to help L. plantarum cope with adverse stress, which will help probiotics become less vulnerable to antibiotics during clinical treatment.